Clinically Significant Differences Between P2Y12 Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be Demonstrated

被引：0
|
作者：
Bates, Eric R. [1 ]
机构：
[1] Cardiovasc Ctr Michigan Med, 1500 East Med Ctr Dr,2A192A, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 01期
关键词：
DUAL ANTIPLATELET THERAPY; P2Y(12) INHIBITOR; SECONDARY PREVENTION; METAANALYSIS;
D O I：
10.1016/j.jacc.2023.09.833
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e9 / e10
页数：2
相关论文
共 50 条
  • [1] P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
    Gragnano, Felice
    Cao, Davide
    Pirondini, Leah
    Franzone, Anna
    Kim, Hyo-Soo
    von Scheidt, Moritz
    Pettersen, Alf-Age R.
    Zhao, Qiang
    Woodward, Mark
    Chiarito, Mauro
    McFadden, Eugene P.
    Park, Kyung Woo
    Kastrati, Adnan
    Seljeflot, Ingebjorg
    Zhu, Yunpeng
    Windecker, Stephan
    Kang, Jeehoon
    Schunkert, Heribert
    Arnesen, Harald
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    Calabro, Paolo
    Pocock, Stuart
    Mehran, Roxana
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (02) : 89 - 105
  • [2] P2Y12 Inhibitor-Based Monotherapy
    Choudhary, Rahul
    Deora, Surender
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1273 - 1274
  • [3] P2Y12 Inhibitor Monotherapy Is Superior to Aspirin Monotherapy in Chronic Limb-Threatening Ischemia Postendovascular Intervention
    Fakhoury, Elias
    Khan, Sikandar
    O'Brien-Irr, Monica
    Dosluoglu, Hasan H.
    Harris, Linda
    Rivero, Mariel
    Cherr, Gregory
    Dryjski, Maciej
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : E248 - E248
  • [4] P2Y12 INHIBITOR MONOTHERAPY VERSUS CONVENTIONAL DUAL ANTIPLATELET THERAPY OR ASPIRIN MONOTHERAPY IN ACUTE CORONARY SYNDROME
    Song, P. -S.
    ATHEROSCLEROSIS, 2021, 331 : E266 - E266
  • [5] P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
    Kim, Juwon
    Jang, Woo Jin
    Lee, Wang Soo
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Bin Song, Young
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Oh, Ju-Hyeon
    Chun, Woo Jung
    Park, Yong Hwan
    Im, Eul-Soon
    Jeong, Jin-Ok
    Cho, Byung Ryul
    Oh, Seok Kyu
    Yun, Kyeong Ho
    Cho, Deok-Kyu
    Lee, Jong-Young
    Koh, Young-Youp
    Bae, Jang-Whan
    Choi, Jae Woong
    Yoon, Hyuck Jun
    Lee, Seung Uk
    Cho, Jang Hyun
    Choi, Woong Gil
    Rha, Seung-Woon
    Hahn, Joo-Yong
    HEART, 2021, 107 (13) : 1077 - 1083
  • [6] REPLY: P2Y12 Inhibitor-Based Monotherapy
    Angiolillo, Dominick J.
    Baber, Usman
    Dangas, George D.
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1274 - 1275
  • [7] Choosing between aspirin or P2Y12 monotherapy after short course of DAPT
    Kuno, Toshiki
    Ueyama, Hiroki
    Takagi, Hisato
    Bangalore, Sripal
    Kumari, Vimla
    AMERICAN HEART JOURNAL, 2020, 230 : 100 - 100
  • [8] P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: Is It Safe to Abandon Aspirin?
    Feng, Wen-Han
    Hsieh, I-Chang
    Li, Yi-Heng
    ACTA CARDIOLOGICA SINICA, 2021, 37 (01) : 1 - 8
  • [9] P2Y12 inhibitor monotherapy is associated with superior outcomes as compared with aspirin monotherapy in chronic limb-threatening ischemia
    Khan, Sikandar Z.
    O'Brien-Irr, Monica S.
    Fakhoury, Elias
    Montross, Brittany
    Rivero, Mariel
    Dosluoglu, Hasan H.
    Harris, Linda M.
    Dryjski, Maciej L.
    JOURNAL OF VASCULAR SURGERY, 2022, 76 (04) : 1053 - 1059
  • [10] P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?
    Gragnano, Felice
    Capolongo, Antonio
    Calabro, Paolo
    CURRENT VASCULAR PHARMACOLOGY, 2024, 22 (01) : 1 - 4
12345